why choose us

First received: December 15, 2024

Clinical Trial: A Study to Find Out How Litifilimab is Processed in the Body in Healthy Participants When Given Under the Skin in 3 Different Ways

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Volunteer

Study Type: INTERVENTIONAL


Official Title: A Randomized, Open-Label, 2-Arm, 2-Part, Parallel Group Study to Assess the Pharmacokinetic Comparability of Subcutaneously Administered Litifilimab (BIIB059) Delivered by 3 Devices (Pre-Filled Syring

Brief Summary: In this study, researchers will learn how the body processes litifilimab when it is given under the skin in 3 different ways.Currently, ongoing studies utilize pre-filled syringes (PFS) that can deliver litifilimab subcutaneously (SC), also known as under the skin.In this study, researchers want to learn more about new ways of delivering litifilimab SC using either an autoinjector (AI) or an on-body injector (OBI):Both devices are designed to deliver litifilimab in an automatic way, especially helping patients who…

Read more